Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

83
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
83
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

224
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
224
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

150
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
150
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

176
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
176
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

86
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
86
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

141
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
141

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stop antibiotics when you feel better? Opportunities, challenges and research directions.

JAC-antimicrobial resistance·2024
Same author

Lower-limb intramedullary nailing in patients with polyostotic fibrous dysplasia who had a previous unsuccessful treatment. A report of 48 cases.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology·2023
Same author

Infection rate of intramedullary nailing for treatment of lower limb polyostotic fibrous dysplasia.

Journal of biological regulators and homeostatic agents·2020
Same author

Structured reporting of chest CT in COVID-19 pneumonia: a consensus proposal.

Insights into imaging·2020
Same author

Prenatal exposure to different diets influences programming of glucose and insulin metabolism in dairy ewes.

Journal of dairy science·2020
Same author

Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®).

European review for medical and pharmacological sciences·2018
Same journal

RETRACTION: Isolation of Antidiabetic Principle from Fruit Rinds of <i>Punica granatum</i>.

Evidence-based complementary and alternative medicine : eCAM·2026
Same journal

RETRACTION: Molecular Mechanism of Traditional Chinese Ointment of Xuzhou Qufu Shengji in Infected Wounds.

Evidence-based complementary and alternative medicine : eCAM·2026
Same journal

RETRACTION: Involvement of Endoplasmic Reticulum Stress in Capsaicin-Induced Apoptosis of Human Pancreatic Cancer Cells.

Evidence-based complementary and alternative medicine : eCAM·2026
Same journal

RETRACTION: Thujone-Rich Fraction of <i>Thuja occidentalis</i> Demonstrates Major Anti-Cancer Potentials: Evidences from In Vitro Studies on A375 Cells.

Evidence-based complementary and alternative medicine : eCAM·2026
Same journal

RETRACTION: Application of <i>Antrodia camphorata</i> Promotes Rat's Wound Healing <i>In Vivo</i> and Facilitates Fibroblast Cell Proliferation <i>In Vitro</i>.

Evidence-based complementary and alternative medicine : eCAM·2026
Same journal

RETRACTION: Catechins and Sialic Acid Attenuate <i>Helicobacter pylori</i>-Triggered Epithelial Caspase-1 Activity and Eradicate <i>Helicobacter pylori</i> Infection.

Evidence-based complementary and alternative medicine : eCAM·2026
See all related articles

Related Experiment Video

Updated: Oct 29, 2025

Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

16.4K

Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis.

A Ledda1, S Hu1, M R Cesarone1

  • 1IRVINE3 Vascular/Circulation Labs CH-PE University, Pescara, Italy.

Evidence-Based Complementary and Alternative Medicine : Ecam
|July 14, 2021
PubMed
Summary
This summary is machine-generated.

Pycnogenol® supplementation significantly reduced urinary tract infections (UTIs) and interstitial cystitis (IC) symptoms in a pilot study. Pycnogenol® proved more effective than cranberry extract and standard management, with no reported side effects.

More Related Videos

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.4K
Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice
10:23

Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice

Published on: December 1, 2017

17.3K

Related Experiment Videos

Last Updated: Oct 29, 2025

Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

16.4K
Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.4K
Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice
10:23

Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice

Published on: December 1, 2017

17.3K

Area of Science:

  • Urology
  • Natural Product Research
  • Pharmacology

Background:

  • Recurrent urinary tract infections (UTIs) and interstitial cystitis (IC) significantly impact quality of life.
  • Prophylactic strategies for UTIs and IC often involve antibiotics or supplements.
  • Limited comparative data exists for natural supplements like Pycnogenol® and cranberry extract in managing these conditions.

Purpose of the Study:

  • To evaluate and compare the prophylactic efficacy of Pycnogenol® and cranberry extract in individuals with a history of recurrent UTIs or IC.
  • To assess the safety and tolerability of these natural supplements over a 2-month period.
  • To determine if Pycnogenol® or cranberry extract offer superior benefits compared to standard management alone.

Main Methods:

  • An open pilot registry study involving 64 subjects diagnosed with recurrent UTIs or IC.
  • Subjects were divided into three groups: Pycnogenol® (150 mg/day), cranberry extract (400 mg/day), or standard management (control).
  • A 2-month follow-up period was conducted to monitor UTI/IC symptom incidence, recurrence rates, and overall symptom severity.

Main Results:

  • All 64 participants experienced significant UTI/IC symptoms at baseline; no side effects were reported during the study.
  • The Pycnogenol® group showed a significantly greater decrease in UTI symptoms and infection rates compared to the control group (p < 0.05).
  • Pycnogenol® supplementation resulted in a higher percentage of infection-free subjects (100%) and symptom-free subjects (20/22) compared to cranberry extract and standard management.

Conclusions:

  • Pycnogenol® supplementation over 60 days appears to be a safe and effective option for reducing the occurrence of UTIs and IC.
  • The prophylactic efficacy of Pycnogenol® in managing UTIs and IC was found to be superior to cranberry extract.
  • This pilot study suggests Pycnogenol® as a promising alternative for individuals seeking non-antibiotic approaches for recurrent UTIs and IC.